HOUSTON---June 3, 2014---GE (NYSE: GE) today announced that it has successfully completed its acquisition of Cameron's Reciprocating Compression division for $550 million USD.
The division provides reciprocating compression equipment and aftermarket parts and services for oil and gas production, gas processing, gas distribution and independent power industries. Cameron's Reciprocating Compression division has approximately 900 employees and operates from 20 global locations.
Next-generation OligoProcess system has potential to help pharmaceutical industry save time and money
CHALFONT ST. GILES, UK and FRANKFURT, GERMANY -- 13 May 2014 -- GE Healthcare Life Sciences (NYSE: GE) and German oligonucleotide manufacturer BioSpring GmbH announced today that BioSpring has selected and installed GE Healthcare Life Sciences' OligoProcess, a fully automated oligonucleotide synthesizer, as a core element of its state-of-the-art production facility in Frankfurt.
business unit
tags
Putting interventional radiologists in the center of their procedures
Wauwatosa, WI -- April 30, 2014 -- GE Healthcare announced today it has received Food and Drug Administration (FDA) clearance for its Discovery* IGS 740, a new rail-free mobile angiography system with a 41x41-cm detector. The Discovery IGS 740 is the first of this kind of mobile angiography system in the industry to receive FDA approval.
business unit
tags
Barrington, IL -- April 15, 2014 -- GE Healthcare announced today it has completed the acquisition of CHCA Computer Systems Inc., an operating room (OR) management and analytics solutions provider, headquartered in Montreal, Canada. CHCA develops the leading Opera software application, which has helped increase productivity and patient satisfaction in the OR by providing real-time data to support the decision making and management of surgical procedures.
business unit
tags
Prototype device testing shows that GE's RF MEMS switch can help enable increased data transfer speeds, enhanced signal quality, longer battery life, and the advanced RF designs required of LTE-Advanced devices.
Videos demonstrating GE's MEMS technology available at: http://youtu.be/DXRsHjxHWEE and http://youtu.be/_RFBheVJbMs
business unit
tags
WAUKESHA, Wisc. -- Molecular Breast Imaging (MBI) Clinical Indications, Benefits and Challenges is the focus of a new CME credit course to be offered by ICPME® and funded in part by Gamma Medica, Inc. and in part by GE Healthcare. The one-hour online session will provide a thorough overview of MBI, which is a growing imaging technology for women with dense breasts and certain difficult-to-image cancers.
business unit
tags
CEO Jeff Immelt in Annual Letter to Shareowners: "We are transforming GE around the culture of Simplification."
GE today released its 2013 Annual Report, available at www.ge.com/annualreport. The title of the report is "Progress," also the theme of GE Chairman and CEO Jeff Immelt's letter to shareowners. "Progress is about getting better, being better, doing better; this is why GE people get up every day," Immelt writes.